Palanocin-V 0.25 mg Injection 5 ml

Palanocin-V 0.25 mg Injection 5 ml belongs to a class of drugs called antiemetics used to prevent nausea and vomiting during chemotherapy. Nausea is a feeling of uneasiness of the stomach that often comes before vomiting. On the other hand, vomiting is the forcible voluntary or involuntary emptying of stomach contents through the mouth.

Palanocin-V 0.25 mg Injection 5 ml contains Palonosetron which works by blocking the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting.

Palanocin-V 0.25 mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience diarrhoea, constipation, dizziness or headache. Most of these side effects of Palanocin-V 0.25 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Palanocin-V 0.25 mg Injection 5 ml or any other medicines, please tell your doctor. Palanocin-V 0.25 mg Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palanocin-V 0.25 mg Injection 5 ml. Drive only if you are alert as Palanocin-V 0.25 mg Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.

Palanocin-V 0.25 mg Injection 5 ml is used in the treatment of Nausea and vomiting. The detailed uses of Palanocin-V 0.25 mg Injection 5 ml are as follows:

• Chemotherapy-Induced Nausea and Vomiting (CINV): Palanocin-V 0.25 mg Injection 5 ml prevents acute and delayed CINV, providing long-lasting relief and improving patient quality of life during chemotherapy.
• Postoperative Nausea and Vomiting (PONV): Palanocin-V 0.25 mg Injection 5 ml prevents PONV, reducing patient discomfort and promoting smoother recovery after surgery.

• Palanocin-V 0.25 mg Injection 5 ml is administered only in clinical settings by healthcare professionals, usually through intravenous or intramuscular injections.
• The dosage and timing are decided by the doctor, depending on the cause and severity of symptoms.
• Do not self-administer this medication.
• Patients are monitored during and after administration to ensure safety and effective control of symptoms.

Palanocin-V 0.25 mg Injection 5 ml contains Palonosetron which blocks the action of serotonin, a chemical that stimulates the vomiting centre (chemoreceptor trigger zone – CTZ) located in the brain. Thus, it prevents nausea and vomiting during chemotherapy.

If you are allergic to Palanocin-V 0.25 mg Injection 5 ml or any other medicines, please tell your doctor. Palanocin-V 0.25 mg Injection 5 ml may be given to children above 1 month in doses as advised by a doctor based on the child's body weight. If you are pregnant or breastfeeding, please inform your doctor before taking Palanocin-V 0.25 mg Injection 5 ml. Drive only if you are alert as Palanocin-V 0.25 mg Injection 5 ml may cause tiredness or dizziness. You are recommended to avoid heavy meals and take small nourishing snacks throughout the day. Drink plenty of water to avoid dehydration.